Listeriolysin O potentiates immunotoxin and bleomycin cytotoxicity

Bioconjugate Chemistry

Volumn 8, Issue 6, 1997, Pages 781-784

  Kerr, David E ^a   Wu, George Y ^b   Wu, Catherine H ^b   Senter, Peter D ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXICITY; PATHOGENS; PEPTIDES;

ANTI-TUMORS; ANTICANCER DRUG; ANTITUMOR ANTIBODIES; BLEOMYCINS; CYTOTOXIC ACTIVITIES; IMMUNOTOXINS; IN-VITRO; LISTERIOLYSIN O; RIBOSOME-INACTIVATING PROTEIN; VITRO CYTOTOXICITIES;

CHAINS;

BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES;

EID: 0031281980     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970124+     Document Type: Article

References (25)

1. Vitetta, E. S. (1994) From the basic science of B cells to biological missiles at the bedside. J. Immunol. 153, 1407-1420.
2. Press, O. W. (1991) Immunotoxins. Biotherapy 3, 65-76.
3. Pastan, I., Pai, L. H., Brinkmann, U., and FitzGerald, D. (1996) Recombinant immunotoxins. Breast Cancer Res. Treat. 38, 3-9.
4. Byers, V. S., Pawluczyk, I. Z., Hooi, D. S., Price, M. R., Carroll, S., Embleton, M. J., Garnett, M. C., Berry, N., Robins, R. A., and Baldwin, R. W. (1991) Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action. Cancer Res. 51, 1990-1995.
5. Bilge, A., Howell-Clark, J., Ramakrishnan, S., and Press, O. W. (1994) Degradation of ricin A chain by endosomal and lysosomal enzymes - the protective role of ricin B chain. Ther. Immunol. 1, 197-204.
6. Kornfeld, S. B., Leonard, J. E., Mullen, M. D., and Taetle, R. (1991) Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas. Cancer Res. 51, 1689-1693.
7. Carayon, P., Bord, A., Gaillard, J. P., Vidal, H., Gros, P., and Jansen, F. K. (1993) Ricin A-chain cytotoxicity depends on its presentation to the cell membrane. Bioconjugate Chem. 4, 146-152.
8. Marsh, J. W. (1989) Cellular processing of a ricin-antibody conjugate. J. Biol. Chem. 264, 10405-10410.
9. Dosio, F., Franceschi, A., Ceruti, M., Brusa, P., Cattel, L., and Colombatti, M. (1996) Enhancement of ricin toxin A chain immunotoxin activity: synthesis, ionophoretic ability, and in vitro activity of monensin derivatives. Biochem. Pharmacol. 52, 157-166.
10. Chignola, R., Anselmi, C., Dalla Serra, M., Franceschi, A., Fracasso, G., Pasti, M., Chiesa, E., Lord, J. M., Tridente, G., and Colombatti, M. (1995) Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures. J. Biol. Chem. 270, 23345-23351.
11. Geoffroy, C., Gaillard, J. L., Alouf, J. E., and Berche, P. (1987) Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect. Immun. 55, 1641-1646.
12. Mengaud, J., Vincente, M.-F., Chenvert, J., Pereira J. M., Geoffrey, C., Gicquel-Sanzey, B., Baquero, F., Perez-Diaz, J.-C., and Cossart, P. (1988) Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect. Immun. 56, 766-772.
13. Cossart, P., Vicente, M. F., Mengaud, J., Baquero, F., Perez-Diaz, J.-C., and Berche, P. (1989) Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect. Immun. 57, 3629-3636.
14. Bielecki, J., Youngman, P., Connelly, P., and Portnoy, D. A. (1990) Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature 345, 175-176.
15. Svensson, H. P., Vrudhula, V. M., Emswiler J. E., MacMaster, J. F., Cosand, W. L., Senter, P. D., and Wallace, P. M. (1995) In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody β-lactamase conjugates. Cancer Res. 55, 2357-2365.
16. y-related cell surface antigens. Cancer Res. 50, 2183-2190.
17. Hellström, I., Horn, D., Linsley, P., Brown, J. P., Brankovan V., and Hellström, K. E. (1986) Monoclonal mouse antibodies raised against human lung carcinoma. Cancer Res. 46, 3917-3923.
18. Mattes, M. J., Griffiths, G. L., Diril, H., Goldenberg, D. M., Ong, G. L., and Shih, L. B. (1994) Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells. Cancer 73, 787-793.
19. Schmidberger, H., King, L., Lasky, L. C., and Vallera, D. A. (1990) Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo. Cancer Res. 50, 3249-3256.
20. Chabner, B. A., and Myers, C. E. (1993) Antitumor antibiotics. Cancer: Principles and Practice of Oncology (V. T. J. DeVita, S. Hellman, and S. A. Rosenberg, Eds.) pp 374-376, J. B. Lippincott Co., Philadelphia.
21. Hecht, S. M. (1994) RNA degradation by bleomycin, a naturally occurring bioconjugate. Bioconjugate Chem. 5, 513-526.
22. Pron, G., Belehradek, J., Jr., and Mir, L. M. (1993) Identification of a plasma membrane protein that specifically binds bleomycin. Biochem. Biophys. Res. Commun. 194, 333-337.
23. Shimizu, N., and Kawazoe, Y. (1996) A new method for permeabilization of cultured cells without cell damage. Biol. Pharm. Bull. 19, 484-486.
24. Tounekti, O., Pron, G., Belehradek, J., Jr., and Mir, L. M. (1993) Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res. 53, 5462-5469.
25. Senter, P. D., Saulnier, M. G., Schreiber, G. J., Hirschberg, D. L., Brown, J. P., Hellstrom, I., and Hellstrom, K. E. (1988) Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. Proc Natl. Acad. Sci. U.S.A. 85, 4842-4846.